Axonics stock gains after Nasdaq delisting notice for sale to Boston Scientific

SCHLX Fund  USD 42.93  0.04  0.09%   
Slightly above 62% of Deutsche Health's investor base is looking to short. The analysis of overall sentiment of trading Deutsche Health And mutual fund suggests that many investors are alarmed at this time. Deutsche Health's investing sentiment can be driven by a variety of factors including economic data, Deutsche Health's earnings reports, geopolitical events, and overall market trends.
  
Axonics stock edged higher by 0.7 percent after receiving a Nasdaq delisting notice due to its planned sale to Boston Scientific.

Read at seekingalpha.com
seekingalpha News
  

Deutsche Health Fundamental Analysis

We analyze Deutsche Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Deutsche Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Deutsche Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Three Year Return

Three Year Return Comparative Analysis

Deutsche Health is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.

Deutsche Health And Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Deutsche Health mutual fund to make a market-neutral strategy. Peer analysis of Deutsche Health could also be used in its relative valuation, which is a method of valuing Deutsche Health by comparing valuation metrics with similar companies.

Other Information on Investing in Deutsche Mutual Fund

Deutsche Health financial ratios help investors to determine whether Deutsche Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Deutsche with respect to the benefits of owning Deutsche Health security.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated